Open AccessLow‐volume, high‐throughput sandwich immunoassays for profiling plasma proteins in mice: Identification of early‐stage systemic inflammation in a mouse model of intestinal cancer
Author(s) -
Forrester Sara,
Hung Kenneth E.,
Kuick Rork,
Kucherlapati Raju,
Haab Brian B.
Publication year - 2007
Publication title -
molecular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1016/j.molonc.2007.06.001
Subject(s) - mutant , immunoassay , biology , cancer , inflammation , blood proteins , cancer cell , cancer research , microbiology and biotechnology , immunology , antibody , gene , biochemistry , genetics
Mouse models of human cancers may provide a valuable resource for the discovery of cancer biomarkers. We have developed a practical strategy for profiling specific proteins in mouse plasma using low‐volume sandwich‐immunoassays. We used this method to profile the levels of 14 different cytokines, acute‐phase reactants, and other cancer markers in plasma from mouse models of intestinal tumors and their wild‐type littermates, using as little as 1.5μl of diluted plasma per assay. Many of the proteins were significantly and consistently up‐regulated in the mutant mice. The mutant mice could be distinguished nearly perfectly from the wild‐type mice based on the combined levels of as few as three markers. Many of the proteins were up‐regulated even in the mutant mice with few or no tumors, suggesting the presence of a systemic host response at an early stage of cancer development. These results have implications for the study of host responses in mouse models of cancers and demonstrate the value of a new low‐volume, high‐throughput sandwich‐immunoassay method for sensitively profiling protein levels in cancer.